SPARKS, MD -- (MARKET WIRE) -- September 07, 2006 -- Today, BioniCare Medical Technologies, Inc. announced the publication of its Phase IV, Open Label study in Surgical Technology International (STI) demonstrating the safety and efficacy of the BioniCare Knee Device for patients with osteoarthritis of the knee. The data not only demonstrate a significant dose response relationship between efficacy and hours of usage with the BioniCare Knee Device but also demonstrates a significant decrease or discontinuation in non-steroidal anti-inflammatory drug (NSAID) usage.
